Survival after reoperation for recurrent glioblastoma
Royce W. Woodroffe(University of Iowa), Jeremy D.W. Greenlee(University of Iowa Hospitals and Clinics), Neha Dhungana(University of Iowa), Karra A. Jones(Duke University), Logan Helland(University of Iowa), Joan E. Maley(University of Wisconsin–Madison), Varun Monga(University of Iowa), Arham Pasha(University of Iowa), Neetu Soni(University of Iowa Hospitals and Clinics), Mario Zanaty(University of Iowa), Sarah L. Mott(University of Iowa)
Cited by 24
Related Papers
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274
Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study
|BJOG An International Journal of Obstetrics & Gynaecology|1995|215
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
|JAMA Network Open|2023|117
Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer
|Cancer Research|2015|111